An Investigator Initiated, Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of Glycopyrrolate/Formoterol on Exercise Tolerance and Dynamic Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 22 Feb 2018 Planned End Date changed from 1 Dec 2018 to 31 Dec 2019.
- 22 Feb 2018 Planned primary completion date changed from 1 Dec 2018 to 31 Dec 2018.
- 10 Apr 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2018.